Company Reports

2026 is proving to be another excellent year for CME, as high trading volume and surging market data revenue have combined to drive impressive growth from an already strong performance in 2025, with third-quarter diluted earnings per share up 13% from last year.

Market conditions have remained favorable for CME Group so far in 2026, as high macroeconomic and geopolitical uncertainty has driven strong trading volume across all of its asset classes. We expect this tailwind to persist for the rest of 2026 before diminishing in 2027, contributing to our expectation for a deceleration in growth next year. That said, CME is a direct beneficiary of economic uncertainty. As long as market conditions remain volatile, we expect the firm to continue to deliver strong profitability.

CME reported strong third-quarter earnings as high market activity led to higher trading volume and transaction revenue. Revenue rose 13% from last year to $1.7 billion, while diluted earnings per share increased to $2.90 from $2.49.

CME reported solid second-quarter earnings as impressive market data revenue growth offset lower trading revenue. Net revenue increased 0.8% from last year to 1.7 billion, while earnings per share rose to $2.89 from $2.81 in the prior year.

CME announced that after leading the company for over 25 years, Terrence Duffy will give up control of the firm on March 1, 2027.

CME reported very strong first-quarter earnings as volatile market conditions led to surging trading revenue. Revenue increased 14.5% to $1.88 billion while diluted earnings per share rose to $3.18 from $2.62 last year.

CME Group enjoyed favorable market conditions in 2025, as volatility across multiple asset classes drove higher trading volume, resulting in strong revenue growth. CME has enjoyed accelerated revenue growth since 2022, as heightened interest-rate uncertainty has led to sustained growth in interest-rate futures volume. We expect this tailwind to persist in 2026 before diminishing in 2027, contributing to our expectation for a deceleration in growth next year.

CME Group enjoyed favorable market conditions in 2025, as volatility across multiple asset classes drove higher trading volume, resulting in strong revenue growth. CME has enjoyed accelerated revenue growth since 2022, as heightened interest-rate uncertainty has led to sustained growth in interest-rate futures volume. We expect this tailwind to persist in 2026 before diminishing in 2027, contributing to our expectation for a deceleration in growth next year.

CME Group enjoyed favorable market conditions in 2025 as volatility across multiple asset classes drove increased trading volume, leading to strong revenue growth. CME has enjoyed a period of accelerated revenue growth since 2022, as increased interest rate uncertainty has led to a sustained increase in interest rate futures volume. We expect this tailwind to persist in 2026 before diminishing in 2027, contributing to our expectation for a deceleration in growth next year.

CME reported a strong end to an excellent 2025, thanks to particularly high market activity in its equity and metals futures businesses during the fourth quarter. Revenue increased 8.1% to $1.65 billion while adjusted earnings per share rose to $2.77 from $2.52 last year.

CME reported decent third-quarter results as trading activity normalized from recent highs. Revenue fell 3% from last year and 9% from last quarter to $1.54 billion. Meanwhile, earnings per share fell to $2.49 from $2.51 as higher expenses were offset by strong nonoperating income.

CME Group enjoyed favorable market conditions in 2024 as volatility across multiple asset classes drove increased trading volume, leading to strong revenue growth. Before 2023, the most significant headwind for the company had been the impact that low short-term interest rates had on its interest-rate futures, which are its largest source of revenue. When interest rates are expected to stay low, there is less need for interest-rate hedging and less incentive for speculation, creating a drag on CME's trading volume. However, since 2023 this complacency has been replaced by heightened uncertainty, swinging interest-rate futures volume from a cyclical low to a cyclical high, driving accelerated growth. That said, we think this tailwind has mostly played out, and we expect interest-rate futures growth to be slower once conditions normalize.

CME reported another strong quarter thanks to high trading volume and good expense management. Revenue increased 10.4% from last year to $1.9 billion, and diluted earnings per share increased 16.1% to $2.81.

CME reported strong first-quarter results thanks to high market activity across all its asset classes. Revenue increased 10% to $1.6 billion, and diluted earnings per share increased 11.5% to $2.62.

CME Group has been enjoying a string of strong results as the firm sees strong futures trading activity across its business. Trading volume rose 11% in 2024 with interest rate and commodity futures setting new all-time highs.

CME Group enjoyed favorable market conditions in 2024 as volatility across multiple asset classes drove increased trading volume, leading to strong revenue growth. Before 2023, the most significant headwind for the company had been the impact that low short-term interest rates had on its interest-rate futures, which are its largest source of revenue. When interest rates are expected to stay low, there is less need for interest-rate hedging and less incentive for speculation, creating a drag on CME's trading volume. However, since 2023 this complacency has been replaced by heightened uncertainty, swinging interest-rate futures volume from a cyclical low to a cyclical high, driving accelerated growth. That said, we think this tailwind has mostly played out, and we expect interest-rate futures growth to be slower as conditions normalize.

CME's fourth-quarter results were a solid end to a strong 2024 thanks to strong market activity across multiple futures markets. Revenue increased 6% from the year-ago quarter to $1.5 billion, and earnings per share increased 7.1% to $2.40 despite a higher effective tax rate.

Wide-moat-rated CME group reported strong third-quarter earnings that were in line with our expectations as the company benefits from strong trading volume in multiple major asset classes. Net revenue increased 18% from last year and 3.4% from last quarter to $1.58 billion. Meanwhile, diluted earnings per share increased to $2.50 from $2.06 last year. While these were strong results, they were not surprising as the firm’s monthly trading volume reports had built up expectations heading into the earnings release. As we incorporate these results, we do not expect to materially alter our $225 fair value estimate for CME. We see the shares as fairly valued at the current price.

CME Group has enjoyed favorable market conditions in 2024 as volatility across multiple asset classes drove increased trading volume, leading to strong revenue growth. Before 2022, the most significant headwind for the company had been the impact that low short-term interest rates had on its interest-rate futures, which are its largest source of revenue. When interest rates are expected to stay low, there is less need for interest-rate hedging and less incentive for speculation, creating a drag on CME's trading volume. With interest rates now well above the 0% rate we saw during much of the past decade, the drag has been removed, benefiting the company's growth. After multiple years of elevated volume growth, however, we think this tailwind has played out, and we expect interest-rate futures growth to be slower going forward.

Wide-moat-rated CME Group reported strong second-quarter earnings as the company enjoyed high trading volume growth across all asset classes. Revenue increased 12.7% from last year and 3% from last quarter to $1.53 billion. Meanwhile, diluted earnings per share increased 13% from last year to $2.42, though the company did benefit from one extra trading day in the quarter. As we incorporate these results, we do not expect to materially alter our $225 fair value estimate. We see the company as modestly undervalued at the current price, though we note that once interest rates begin to decline the firm will face headwinds on earnings growth.